Lexicon Pharmaceuticals stock trades near its yearly low

Published on 09/23/2026 at 07:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lexicon Pharmaceuticals stock traded at USD 1.10 on July 25, 2025, while 2 million shares changed hands. The latest report period remains 2025.

LXRX, US5396941031, Illustration mit AI erstellt.

Lexicon Pharmaceuticals stock (ISIN US5396941031) was quoted at USD 1.10 on July 25, 2025, while about 2 million shares changed hands in the cited session. The market data place the biotechnology company in a low-priced, high-volatility segment where trading activity can materially exceed the cash value of the shares.

Trading activity reaches USD 2.59 million

According to StockInvest on September 22, 2026, approximately 2 million LXRX shares were bought and sold for about USD 2.59 million, while the cited share price was USD 1.10 on July 25, 2025. The comparison between the share count and the dollar value shows why volume alone does not establish a fundamental change in the company.

The quoted trading volume also fell by 451,000 shares in the referenced session. That is a decline of approximately 18.4 percent from 2.451 million shares, calculated from the source figures, although the source does not provide a same-day September 23, 2026 closing quote for LXRX.

Historical figures need a clear date

The available market page identifies the USD 1.10 quotation as a July 25, 2025 value rather than a September 23, 2026 price. It therefore serves as historical market context, not as a current closing level. The source also reports approximately USD 2.59 million in traded value for the referenced session, giving investors a dated liquidity measure alongside the share price.

Lexicon Pharmaceuticals remains a biotechnology issuer whose investment case depends on clinical development, regulatory progress and commercial execution. Those company-specific factors are not quantified in the available market extract, so the dated trading figures carry the article's measurable market signal.

Stock remains a dated market indicator

Lexicon Pharmaceuticals stock was quoted at USD 1.10 on July 25, 2025, with approximately 2 million shares traded and about USD 2.59 million in reported turnover. These figures describe the cited market session and do not constitute an investment recommendation.